3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
4
Nasopharyngeal Carcinoma
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Meningioma
2
Liver Neoplasms
2
HER2-positive Breast Cancer
2
Glioma
2
Glioblastoma
2
Chordoma
2
Carcinoma, Hepatocellular
2
Carcinoma, Adenoid Cystic
2
Brain Neoplasms
2
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Small Cell Lung Carcinoma
1
Sinonasal undifferentiated carcinoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Radiation Injuries
1
Pituitary Neoplasms
1
Oligodendroglioma
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Interventions
tanezumab
1
siltuximab
1
erenumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Saline Solution
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Protons
1
Proton Therapy
1
Mn-PyC3A
1
Lapatinib
1
Hyperspectral Imaging
1
HDAC-42
1
Bevacizumab
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neurilemmoma
×
Protons
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled